Literature DB >> 12197867

Biological warfare in a historical perspective.

R Roffey1, A Tegnell, F Elgh.   

Abstract

There are some early examples of biological warfare (BW), but in modern times it was used first for sabotage by Germany during WWI. Development of biological weapons on a military significant scale was initiated in several countries in the period between the world wars. During WWII, several countries had active programs such as the USA, UK, Canada, Germany, Japan and the Soviet Union. It was only Japan that on a fairly large scale used BW. The US program continued until 1969, when President Nixon took a decision to end it in connection with signing the BTWC. The Soviet Union had also continued its program after the war, and this was enhanced after signing the BTWC: in the 1980s the program consisted of around fifty facilities and involved around 60,000 people. The Soviet Union produced and maintained a large stockpile of BW-agents. After the collapse of the Soviet Union, and due to pressure from USA and UK, President Yeltsin issued a decree in 1992 banning continued offensive BW activity. However, there are still concerns of residual activity in Russia. Another program of concern is the Iraqi BW-program. After 10 years of UN inspections that were stopped in 1998, there are still many unanswered questions concerning the BW program. There was also a covert BW-program in South Africa that was terminated around 1993. There have also been a number of allegations of alleged use or possession. In addition, there are indications that 10-12 states are now trying to acquire BW, and this assessment is based on intelligence information, mainly from the USA. For example Iraq, North Korea, Iran, Syria, Sudan and Libya. Another aspect is the strong driving force of technology developments to promote this type of program, opening new risks for future potential military misuse.

Entities:  

Mesh:

Year:  2002        PMID: 12197867     DOI: 10.1046/j.1469-0691.2002.00501.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets.

Authors:  Tracy R Clinton; Matthew T Weinstock; Michael T Jacobsen; Nicolas Szabo-Fresnais; Maya J Pandya; Frank G Whitby; Andrew S Herbert; Laura I Prugar; Rena McKinnon; Christopher P Hill; Brett D Welch; John M Dye; Debra M Eckert; Michael S Kay
Journal:  Protein Sci       Date:  2014-10-31       Impact factor: 6.725

Review 2.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

3.  Pathema: a clade-specific bioinformatics resource center for pathogen research.

Authors:  Lauren M Brinkac; Tanja Davidsen; Erin Beck; Anuradha Ganapathy; Elisabet Caler; Robert J Dodson; A Scott Durkin; Derek M Harkins; Hernan Lorenzi; Ramana Madupu; Yinong Sebastian; Susmita Shrivastava; Mathangi Thiagarajan; Joshua Orvis; Jaideep P Sundaram; Jonathon Crabtree; Kevin Galens; Yongmei Zhao; Jason M Inman; Robert Montgomery; Seth Schobel; Kevin Galinsky; David M Tanenbaum; Adam Resnick; Nikhat Zafar; Owen White; Granger Sutton
Journal:  Nucleic Acids Res       Date:  2009-10-20       Impact factor: 16.971

Review 4.  Biowarfare, bioterrorism and biocrime: A historical overview on microbial harmful applications.

Authors:  Manuela Oliveira; Gabriella Mason-Buck; David Ballard; Wojciech Branicki; António Amorim
Journal:  Forensic Sci Int       Date:  2020-06-20       Impact factor: 2.395

Review 5.  A Systematic Review of Risk Analysis Tools for Differentiating Unnatural From Natural Epidemics.

Authors:  Xin Chen; Abrar Ahmad Chughtai; C Raina MacIntyre
Journal:  Mil Med       Date:  2017-11       Impact factor: 1.437

6.  PgtE Enzyme of Salmonella enterica Shares the Similar Biological Roles to Plasminogen Activator (Pla) in Interacting With DEC-205 (CD205), and Enhancing Host Dissemination and Infectivity by Yersinia pestis.

Authors:  Qiao Li; Chenglin Ye; Fei Zhao; Wenjin Li; Sizhe Zhu; Yin Lv; Chae Gyu Park; Yingmiao Zhang; Ling-Yu Jiang; Kun Yang; Yingxia He; Huahua Cai; Song Zhang; Hong-Hui Ding; Olivia Adhiambo Njiri; John Mambwe Tembo; Ayman Ahmad Alkraiem; An-Yi Li; Zi-Yong Sun; Wei Li; Mei-Ying Yan; Biao Kan; Xixiang Huo; John D Klena; Mikael Skurnik; Andrey P Anisimov; Xiaofang Gao; Yanping Han; Rui-Fu Yang; Xiding Xiamu; Yuanzhi Wang; Hongxiang Chen; Bao Chai; Yicheng Sun; Jingping Yuan; Tie Chen
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

Review 7.  Dangerous Pathogens as a Potential Problem for Public Health.

Authors:  Edyta Janik; Michal Ceremuga; Marcin Niemcewicz; Michal Bijak
Journal:  Medicina (Kaunas)       Date:  2020-11-06       Impact factor: 2.430

8.  Disinformation and Epidemics: Anticipating the Next Phase of Biowarfare.

Authors:  Rose Bernard; Gemma Bowsher; Richard Sullivan; Fawzia Gibson-Fall
Journal:  Health Secur       Date:  2020-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.